Pharmanutra S.p.A.
PHN.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €1 | €1 | €1 | €1 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €1 | €1 | €1 | €1 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 15% | 21.2% | 22.4% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 71.3% | 48.4% | 36.2% | 47.2% |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 27.6% | 26.3% | 29.5% | 29.1% |
| Net Income | €0 | €0 | €0 | €0 |
| % Margin | 14.3% | 12.7% | 18% | 20.2% |
| EPS Diluted | 1.73 | 1.33 | 1.56 | 1.42 |
| % Growth | 30.1% | -14.7% | 9.9% | – |
| Operating Cash Flow | €0 | €0 | €0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €0 | -€0 | -€0 | €0 |